DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Up 1.0%

Thu, 16 Apr 09:42 AM

DIVIS LABORATORIES share price has hit an all-time high at Rs 2,449 (up 1.9%).

Meanwhile, the BSE HEALTHCARE Index is at 14,940 (up 1.0%).

Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 1.9%) and ABBOTT INDIA (up 2.8%).

SYNGENE INTERNATIONAL and LUPIN (down 0.6%) are among the top losers today.

Over the last one year, DIVIS LABORATORIES has moved up from Rs 1,741 to Rs 2,449, registering a gain of Rs 708 (up 40.0%).

The BSE HEALTHCARE has moved up from 14,506 to 14,940, registering a gain of 434 points (up 2.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 124.8%), IPCA LABS (up 62.0%) and ALKEM LABORATORIES (up 56.5%).

REVEALED: The Secret to potentially Making Rs 18,870, Rs 9,425 and Rs 7,315 in a Single Day...

What About the Benchmark Indices?

The BSE Sensex is at 30,263 (down 0.7%). The top gainers among the BSE Sensex stocks today are L&T (up 3.3%), POWER GRID (up 2.6%) and SUN PHARMA (up 2.3%). Other gainers include RELIANCE IND. (up 2.1%) and ONGC (up 1.3%). The most traded stocks in the BSE Sensex are SBI and ONGC.

In the meantime, NSE Nifty is at 9,261 (down 0.8%). The top gainers in the NSE Nifty include UPL (up 7.9%), HUL (up 6.0%) and BRITANNIA (up 4.9%). Other gainers include SHREE CEMENT (up 4.8%) and HCL TECHNOLOGIES (up 4.5%).

Over the last 12 months, the BSE Sensex has moved down from 38,906 to 30,263, registering a loss of -8,643 points (up -22.5%).

DIVIS LABORATORIES Financial Update...

DIVIS LABORATORIES net profit down at Rs 4 billion for the quarter ended December 2019, compared to a loss of Rs 4 billion a year ago. Net Sales rose 3.5% to Rs 13.9 billion during the period as against Rs 13.4 billion in October-December 2018.

For the year ended March 2019, DIVIS LABORATORIES reported 54.2% increase in net profit to Rs 13.5 billion compared to net profit of Rs 8.8 billion during FY18.

Revenue of the company grew 26.4% to Rs 49 billion during FY19.

The current Price to earnings ratio of DIVIS LABORATORIES, based on rolling 12 month earnings, stands at 50.8x.

Indian Share Market Update: Top Gainers and Losers

What else is happening in the markets today? Dig in...